— Know what they know.
Not Investment Advice

NRXS AMEX

NeurAxis, Inc.
1W: -6.0% 1M: +19.5% 3M: -0.7% YTD: +59.4% 1Y: +128.6% 3Y: +74.7%
$7.11
-0.06 (-0.84%)
 
Weekly Expected Move ±13.7%
$5 $6 $7 $8 $9
AMEX · Healthcare · Biotechnology · Tech Score Strong Buy · Power 68 · $88.7M mcap · 9M float · 1.19% daily turnover · Short 51% of daily vol

Supply Chain Overview

13 relationships
13
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2023-08-09
Earliest Filing
2025-09-02
Latest Filing
partner: 5 investor: 3 target: 3 acquirer: 2

Counterparties (Filed by NRXS)

13 relationships

Companies named in NRXS's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Neuraxis, Inc. NRXS partner The company issuing shares in the at-the-market offering. 2025-09-02 View
Craig-Hallum Capital Group LLC — partner The manager appointed as exclusive agent to sell the shares. 2025-09-02 View
Masimo Corporation MASI partner Terminated License Agreement and transferred assets to Neuraxis 2025-07-03 View
Neuraxis, Inc. NRXS partner Terminated License Agreement and acquired assets from Masimo 2025-07-03 View
Neuraxis, Inc. NRXS acquirer Company selling Series B Preferred Stock 2024-10-18 View
Flagstaff International, LLC — investor Investor purchasing Series B Preferred Stock 2024-10-18 View
Neuraxis, Inc. NRXS partner Company issuing convertible promissory note 2024-03-28 View
Flagstaff International, LLC — investor Investor purchasing convertible promissory note 2024-03-28 View
Neuraxis, Inc. NRXS target Company issuing Series B Convertible Preferred Stock and a convertible promissory note to Investor. 2024-02-15 View
NUERAXIS, INC. — target Company issuing Series B Convertible Preferred Stock 2023-11-14 View
FLAGSTAFF INTERNATIONAL, LLC — investor Investor purchasing Series B Convertible Preferred Stock 2023-11-14 View
NEURAXIS, INC. NRXS target Company issuing shares in underwriting agreement 2023-08-09 View
ALEXANDER CAPITAL, L.P. — acquirer Representative underwriter purchasing shares 2023-08-09 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-19 Officer/Director Change; Other Events View
2026-07-10 Other Events View
2026-06-12 Shareholder Vote View
2026-04-22 Other Events; Exhibits View
2026-04-21 Earnings Release View
2025-10-24 Other Events; Financial Statements and Exhibits View
2025-10-23 Results of Operations and Financial Condition View
2025-09-02 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-07-03 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Departure/El Agreement View
2025-06-04 Submission of Matters to a Vote of Security Holders View
2025-05-28 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-05-22 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-05-21 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin Agreement View
2025-01-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-11-25 Departure/Election of Directors; Appointment of Officers View
2024-11-21 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2024-11-15 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2024-11-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-18 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2024-09-13 Unregistered Sales of Equity Securities View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms